Physician profile
Vaishali Doolabh
NPI 1649265463
$305,597.65
in general payments reported to CMS, 2019-2025
13 companies · $45K in 2025
The $45K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $122K · 2021: $1,186 · 2022: $21K · 2023: $59K · 2024: $27K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $110K · Travel and Lodging: $11K · Consulting Fee: $6,475 · Food and Beverage: $2,894 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $110,124.30 |
| Travel and Lodging | $11,482.14 |
| Consulting Fee | $6,475.00 |
| Food and Beverage | $2,893.96 |
| Education | $133.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $142,789.60 | 2019-2020 | |
| Abbvie INC. | $130,675.09 | 2023-2025 | Botox, Kybella, Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $27,751.02 | 2019-2023 | |
| Surgical Innovation Associates, INC. | $3,218.32 | 2022 | |
| Merz North America, INC. | $266.95 | 2020-2021 | |
| Mentor Worldwide LLC | $230.89 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $162.56 | 2024 | |
| W. L. Gore & Associates, INC. | $151.60 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Pacira Pharmaceuticals Incorporated | $133.89 | 2019-2020 | |
| Next Science LLC | $103.01 | 2021 | |
| Tepha INC | $68.89 | 2020 | |
| Bard Peripheral Vascular, INC. | $29.66 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $16.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vaishali Doolabh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.